METHODS FOR THE TREATMENT OF HEPATITIS B AND HEPATITIS D VIRUS INFECTIONS
It is disclosed a method for treating hepatitis B virus infection or hepatitis B virus/hepatits delta virus co-infection, the method comprising administering to a subject in need of such treatment a first pharmaceutically acceptable agent that comprises at least one phosphorothioated nucleic acid polymer and a second pharmaceutically acceptable agent that comprises at least one nucleoside/nucleotide analog HBV polymerase inhibitor.
-
(2016/02/26)
Low dose entecavir formulation and use
Compositions containing a low dose of entecavir are administered on a daily basis to treat hepatitis B virus infection and/or co-infections. Formulations for the oral administration of a low dose of entecavir are provided. Other pharmaceutically active substances can be included in the entecavir composition or can be separately administered for the treatment of hepatitis B virus infection or for the treatment of co-infected patients.
-
(2008/06/13)
Chemical Properties
Appearance/Colour :White crystalline powder
Melting Point: >220°
Boiling Point: 734.2 °C at 760 mmHg
Flash Point:397.9 °C
Density: 1.81 g/cm3
Solubility:DMSO (Slightly), Methanol (Sparingly), Water (Slightly, Heated, Sonicated)
Storage Temp.:Keep in dark place,Sealed in dry,Store in freezer, under -20°C
